Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus
- 1 February 1996
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 45 (2) , 211-217
- https://doi.org/10.1016/s0026-0495(96)90056-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearmJournal of Clinical Endocrinology & Metabolism, 1995
- Effect of lanreotide, a somatostatin analogue, on urea synthesis in normal manClinical Nutrition, 1994
- [13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysisPeptides, 1994
- Mechanism for underestimation of isotopically determined glucose disposalDiabetes, 1989
- Severe Hypoglycemia as a Short-Term Side-Effect of the Somatostatin Analog SMS 201-995 in Insulin-Dependent Diabetes MellitusHormone and Metabolic Research, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Effects of Somatostatin and SMS 201-995 on Carbohydrate Metabolism in Normal ManScandinavian Journal of Gastroenterology, 1986
- Reduced Postprandial Hyperglycemia After Subcutaneous Injection of a Somatostatin-Analogue (SMS 201-995) in Insulin-dependent Diabetes MellitusDiabetes Care, 1985
- Effects of somatostatin on liver glycogen and fat metabolism in vivo.The Japanese Journal of Pharmacology, 1984
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982